[SYRS] QoQ Quarter Result on 30-Jun-2023 [#Q2]

Stock
[SYRS] Syros Pharmaceuticals, Inc.
Announcement Date
08-Aug-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- -142.95%
YoY- -3.03%
Quarter Report
SYRS's Result
SYRS's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Revenue 0 386 3,762 2,833 2,954 -5,467 3,891 -
PBT -3,708 -64,384 -40,143 -36,258 -23,789 -4,774 -30,253 -75.29%
Tax 291 10,883 -3,296 1,278 -8,865 -32,349 -9,201 -
NP -3,708 -64,384 -40,143 -36,258 -14,924 27,575 -21,052 -68.54%
Tax Rate - - - - - - - -
Total Cost 3,708 64,770 43,905 39,091 17,878 -33,042 24,943 -71.90%
Ratio Analysis
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
NP Margin 0.00 -16,679.79 -1,067.07 -1,279.84 -505.21 -504.39 -541.04 -
Per Share
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
EPS -0.10 -2.18 -1.43 -1.30 -0.54 0.99 -2.24 -87.39%
EPS Diluted -0.10 -2.18 -1.43 -1.30 -0.54 0.99 -2.24 -87.39%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.